Search results
Sara Sidner Reveals She’s Undergoing Double Mastectomy to Treat Breast Cancer
People Magazine· 3 days agoSara Sidner is taking the next step in her journey to become cancer-free. The CNN anchor, 51, who...
Candel (CADL) Reports Upbeat Data From Lung Cancer Study
Zacks· 1 day agoCandel's (CADL) CAN-2409 prolongs overall survival in a phase II study for treating patients with advanced non-small cell lung cancer who are non-responsive to immune checkpoint inhibitor therapy.
Alaska Legislature passes cancer-related bills as amendments to other legislation
Alaska Beacon via Yahoo News· 3 days agoAlaska bar patrons will see new signs warning about the link between alcohol and cancer, and women...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga· 17 hours agoVSTM announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2...
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks· 1 day agoBoth avutometinib and defactinib have been in-licensed by Verastem from other pharmaceutical...
Cancer trial sites are growing, but poor performance is, too: report
FierceBiotech· 2 days agoClinical trial sites for cancer are proliferating, but a lack of investigators with experience in trial recruitment is weighing on their performance, according to a report ...
‘Alarming’: Colorectal cancer cases up 500% in children, study finds
WFLA Tampa Bay· 3 days agoColorectal cancer cases are up 500% in children over the last two decades, according to a new study...
Pentagon Chief Lloyd Austin Had ‘Successful’ Follow-Up Medical Procedure
The Wall Street Journal· 6 hours agoDefense Secretary Lloyd Austin underwent a medical procedure Friday night related to a previous...
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...
Nature· 1 day agoInactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly affects cancer development in pancreatic ductal adenocarcinoma (PDAC). However, the ...
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab...
FOX 23 News Albany· 1 day agoThe study, which enrolled patients regardless of their CLDN18.2 and PD-L1 CPS expression, indicated...